There is growing interest in B2B-BP analysis as a key measure of cardiovascular disease (CVD) risk and early-stage disease predictor in pregnancy [21] since recent studies show that 5–10% of all pregnancies [22] affected by hypertension is the most common medical disorder. This evidence concerns the gene KRTAP1-3 and hypertensive disorder.